Literature DB >> 1515980

Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy.

K Nakamura1, T Ueyama, T Yao, Z X Xuan, K Ambe, Y Adachi, Y Yakeishi, A Matsukuma, M Enjoji.   

Abstract

BACKGROUND: Despite recent advances in diagnosis and treatment, gastric carcinoma remains a major cause of death in the world.
METHODS: The clinicopathologic profile of 10,000 consecutive patients who underwent primary gastrectomy during 1962-1989 were reviewed and prognostic factors influencing survival in those with gastric carcinoma were analyzed in 7031 patients.
RESULTS: Incidence of gastrectomy for carcinoma has increased steadily and the rate of early carcinoma exceeded that of advanced carcinoma in the recent period of 1985-1989. Five-year and 10-year survival rates were 46.1% and 35.2% in 3868 patients with advanced carcinoma, and 88.8% and 77.3% in 3163 patients with early carcinoma, respectively. In patients with advanced carcinoma, significantly poorer survival rates were noticed for patients older than 70 years of age, those who underwent total gastrectomy, tumors involving the entire stomach or greater than 10 cm in diameter, a macroscopic diffusely infiltrative pattern, adenosquamous histologic type, positive surgical resection margins, or lymph node metastasis. None of the above poor prognostic features were identified in patients with early gastric carcinoma group except for those older than 70 years of age. Although lymph node metastases were present in 10% of early gastric carcinomas, this feature did not impart a poor prognosis. Patients with advanced carcinoma grossly resembling an early carcinoma had an intermediate prognosis, suggesting the existence of a developmentally midstage lesion between early and advanced carcinoma.
CONCLUSIONS: The study illustrates that the most important role for clinicians treating with gastric carcinoma should be early detection and aggressive surgery for resectable tumors, followed by detailed pathologic examination.

Entities:  

Mesh:

Year:  1992        PMID: 1515980     DOI: 10.1002/1097-0142(19920901)70:5<1030::aid-cncr2820700504>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  98 in total

1.  Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Toshiro Wakatsuki; Masahide Ikeguchi; Ken Shirabe; Masaru Morita; Yoshihiro Kakeji; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

2.  Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.

Authors:  Fumiko Taguchi; Yasuo Kodera; Yasufumi Katanasaka; Kazuyoshi Yanagihara; Tomohide Tamura; Fumiaki Koizumi
Journal:  Invest New Drugs       Date:  2010-06-08       Impact factor: 3.850

3.  Prognostic factors for early gastric cancer in France: Cox regression analysis of 332 cases.

Authors:  Frédéric Borie; Valerie Rigau; Abe Fingerhut; Bertrand Millat
Journal:  World J Surg       Date:  2004-06-16       Impact factor: 3.352

4.  Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer.

Authors:  Evren Fidan; Halil Kavgaci; Asim Orem; Mustafa Yilmaz; Bulent Yildiz; Sami Fidan; Buket Akcan; Feyyaz Ozdemir; Fazil Aydin
Journal:  Tumour Biol       Date:  2012-04-27

5.  Predictors of Lymph Node Metastasis in Western Early Gastric Cancer.

Authors:  Rima Ahmad; Namrata Setia; Benjamin H Schmidt; Theodore S Hong; Jennifer Y Wo; Eunice L Kwak; David W Rattner; Gregory Y Lauwers; John T Mullen
Journal:  J Gastrointest Surg       Date:  2015-09-18       Impact factor: 3.452

6.  Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India.

Authors:  Arun Kumar Barad; Sanjeet Kumar Mandal; Hiriyur S Harsha; Birkumar M Sharma; Th Sudhirchandra Singh
Journal:  J Gastrointest Oncol       Date:  2014-04

7.  Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection.

Authors:  Joong-Min Park; Woo-Sang Ryu; Jong-Han Kim; Sung-Soo Park; Seung-Joo Kim; Chong-Suk Kim; Young-Jae Mok
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

Review 8.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  MR imaging of gastric cancer in vitro: accuracy of invasion depth diagnosis.

Authors:  Chiho Sato; Shinji Naganawa; Hisashi Kumada; Shunichi Miura; Takeo Ishigaki
Journal:  Eur Radiol       Date:  2004-07-17       Impact factor: 5.315

10.  Hyperthermic intraperitoneal chemotherapy (HIPEC) and neoadjuvant chemotherapy as prophylaxis of peritoneal carcinosis from advanced gastric cancer-effects on overall and disease free survival.

Authors:  Federico Coccolini; Andrea Celotti; Marco Ceresoli; Giulia Montori; Michele Marini; Fausto Catena; Luca Ansaloni
Journal:  J Gastrointest Oncol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.